MedPath

HADASSAH MEDICAL ORGANIZATION (CC)

🇮🇱Israel
Ownership
-
Employees
-
Market Cap
-
Website

High Dose D-Serine as Adjuvant Treatment for Recent Onset Schizophrenia

Phase 2
Conditions
Schizophrenia
Interventions
First Posted Date
2011-10-25
Last Posted Date
2011-10-25
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
54
Registration Number
NCT01459029
Locations
🇮🇱

Ezrath Nashim - Herzog Memorial Hospital & Community Clinics, Jerusalem, Israel

🇮🇱

Hadassah Medical Organization, Jerusalem, Israel

T Cell Vaccination in Patients With Progressive Multiple Sclerosis

Phase 1
Completed
Conditions
Multiple Sclerosis
Interventions
Biological: T cell vaccination
Biological: multiple (4 autologous subcutaneous T cell vaccinations with T cell lines reactive to nine myelin peptides)
First Posted Date
2011-10-07
Last Posted Date
2011-10-07
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
30
Registration Number
NCT01448252
Locations
🇮🇱

Dept of Neurology,Hadassah ein-Kerem, Jerusalem, Israel

Insulin Loaded Orally Dissolved Films (Insulin-ODF)

Phase 1
Conditions
Healthy Volunteers
Interventions
Drug: Insulin loaded Orally Dissolved Films (insulin-ODF
Drug: NPH-Insulin Injection
First Posted Date
2011-10-05
Last Posted Date
2011-10-05
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
7
Registration Number
NCT01446120

Transplantation of Ovarian Cortex to Restore Fertility

Not Applicable
Conditions
Pregnancy
Interventions
Procedure: ovarian transplantation
First Posted Date
2011-09-28
Last Posted Date
2011-09-28
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
5
Registration Number
NCT01442584
Locations
🇮🇱

Hadassah, Jerusalem, Israel

Hyaluronic Acid Injection Post Arthroscopy - Does it Improve Immediate Function? Double Blind Controlled Prospective Study

Phase 1
Conditions
Cartilage Injury
Interventions
Device: Hyaluronic Acid Injection
Drug: Saline Injection
First Posted Date
2011-09-28
Last Posted Date
2011-09-28
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
100
Registration Number
NCT01442571

The Impact of RPh201 on Chronic Vegetative State (CVS): fMRI Study

Phase 1
Suspended
Conditions
Chronic Vegetative State
Interventions
Drug: Saline
First Posted Date
2011-09-22
Last Posted Date
2018-02-06
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
10
Registration Number
NCT01438684
Locations
🇮🇱

Netta Levin, Jerusalem, Israel

Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma

Recruiting
Conditions
Uveal Melanoma
First Posted Date
2011-09-22
Last Posted Date
2011-09-28
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
250
Registration Number
NCT01438658
Locations
🇮🇱

Specialized Ocular Oncology Service, Hadassah-Hebrew-University Medical Center, Jerusalem, Israel

Mononucleotide Autologous Stem Cells and Demineralized Bone Matrix in the Treatment of Non Union/Delayed Fractures

Not Applicable
Conditions
Non Union/Delayed Fractures
Interventions
Device: the Sepax is a tool to standardize adult stem cell. Ignite ®ICS injectable scaffold manufactured by Wright Medical Technology.
First Posted Date
2011-09-16
Last Posted Date
2014-03-04
Lead Sponsor
Hadassah Medical Organization
Registration Number
NCT01435434

Breath Test for Patients With Acute Liver Disease for Early Detection of the Need for Transplant or Recovery

Conditions
Acute Liver Failure
First Posted Date
2011-09-16
Last Posted Date
2011-09-16
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
112
Registration Number
NCT01435421

Comparison of Constant Current to Constant Voltage Stimulation in Subthalamic Deep Brain Stimulation for Parkinson's Disease

Not Applicable
Completed
Conditions
Parkinson's Disease
Interventions
Device: Deep Brain Stimulation (Medtronic, Activa PC)
First Posted Date
2011-08-26
Last Posted Date
2015-03-18
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
8
Registration Number
NCT01423565
Locations
🇮🇱

Hadassah University Hospital, Jerusalem, Israel

© Copyright 2025. All Rights Reserved by MedPath